Altimmune announced that it has signed a manufacturing agreement with Summit Biosciences for a multidose version of Altimmune's AdCOVID intranasal vaccine against COVID-19. The announcement comes shortly after Altimmune announced an agreement with Lonza for manufacturing of the single dose version of the vaccine in a dedicated suite at Lonza's Texas facility. A Phase … [Read more...] about Summit Biosciences to produce multidose nasal spray version of Altimmune’s AdCOVID vaccine
Products and Services
Copley launches Inhalytix cascade impactor software
Copley Scientific has launched a new software package for cascade impactor management and data analysis called "Inhalytix," which succeeds the company's long-established CITDAS cascade impactor software. The new software, which is 21 CFR Part 11 compliant, can be used with a variety of cascade impactors, including the NGI, the Andersen impactor, and the Fast Screening … [Read more...] about Copley launches Inhalytix cascade impactor software
Lonza to dedicate manufacturing suite to Altimmune’s AdCOVID intranasal vaccine
In an expansion of a manufacturing agreement between Altimmune and Lonza that was announced in November 2020, Lonza has agreed to dedicate a manufacturing suite at its Texas facility for production of Altimmune's AdCOVID intranasal vaccine. The FDA cleared Altimmune's IND for a Phase 1 trial of AdCOVID in February 2021. According to Altimmune, AdCOVID a single dose … [Read more...] about Lonza to dedicate manufacturing suite to Altimmune’s AdCOVID intranasal vaccine
Copley Scientific introduces new products for nasal spray testing
Copley Scientific, which recently made multiple updates to its range of OINDP testing equipment, has announced the launch of a new range of accessories for testing nasal sprays, including metered dose and dry powder nasal products. The new Copley products include accessories for delivered dose uniformity (DDU) testing of nasal products as well as for improved in … [Read more...] about Copley Scientific introduces new products for nasal spray testing
CounterAct gets US patent for its naloxone nasal spray cap
The US Patent and Trademark Office has issued US Patent No. 10,933,204, titled "Prescription bottle cap capable of administering opioid overdose reversal agent" to CounterAct for its naloxone nasal spray cap, the company said. CounterAct is developing the nasal spray cap, which is designed to snap onto the top of a prescription pill bottle, for the reversal of opioid … [Read more...] about CounterAct gets US patent for its naloxone nasal spray cap
Iconovo gets Indian patent for its ICOone DPI
DPI developer Iconovo announced that it has received its first patent in India covering the company's ICOone single dose DPI. According to the company, the ICOone platform is already covered by patents in Europe, and patents are pending in the US, China, and Japan. In December 2020, Iconovo announced that Monash University had selected ICOone for delivery of its … [Read more...] about Iconovo gets Indian patent for its ICOone DPI
TFF Pharmaceuticals announces agreements for feasibility studies of mRNA vaccine candidate and aviptadil
TFF Pharmaceuticals has announced agreements for feasibility studies with vaccine developer GreenLight Biosciences and with NeuroRx. TFF is performing studies to determine if dry powder formulations of GreenLight's mRNA COVID-19 vaccine candidate and NeuroRx's Zyesami aviptadil can be successfully created using TFF's thin film freezing technology. According to … [Read more...] about TFF Pharmaceuticals announces agreements for feasibility studies of mRNA vaccine candidate and aviptadil
Vectura expands its DPI manufacturing capacity
Inhalation CDMO Vectura has announced the addition of a new dry powder inhaler filling and assembly line at its facility in Chippenham, UK that will increase the company's DPI manufacturing capability to up to 1 million devices per year. The expansion is scheduled to be complete in the second quarter of 2021. The new semi-automatic line will be used for Vectura's … [Read more...] about Vectura expands its DPI manufacturing capacity
Copley announces updates to its OINDP testing equipment range
OINDP testing specialist Copley Scientific has announced upgrades to the company's inhaler testing equipment range, including new products such as the Inhaler Testing Workstation (ITW) and updates to its TPK critical flow controllers, BAC 2100 breath actuated controllers, and BRS breathing simulators. The company has also updated its comprehensive inhaler testing … [Read more...] about Copley announces updates to its OINDP testing equipment range
Herantis partners with Nanoform on intranasal biologics formulation projects
Herantis Pharma has signed an agreement with nanoparticle technology company Nanoform Finland to try out Nanoform's biologics nanoparticle technology for intranasal formulations of CDNF (cerebral dopamine neurotrophic factor). Nanoform launched its nanoparticle technology for biologics in November 2020. Herantis is developing CDNF for the treatment of Parkinson’s … [Read more...] about Herantis partners with Nanoform on intranasal biologics formulation projects